NGL Fine-Chem (BOM:524774) Interest Expense : ₹-13 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NGL Fine-Chem's interest expense for the three months ended in Mar. 2024 was ₹ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-13 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NGL Fine-Chem's Operating Income for the three months ended in Mar. 2024 was ₹ 126 Mil. NGL Fine-Chem's Interest Expense for the three months ended in Mar. 2024 was ₹ -5 Mil. NGL Fine-Chem's Interest Coverage for the quarter that ended in Mar. 2024 was 27.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NGL Fine-Chem Interest Expense Historical Data

The historical data trend for NGL Fine-Chem's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem Interest Expense Chart

NGL Fine-Chem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-22.55

-18.40

-15.62

-11.97

-13.38

NGL Fine-Chem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-3.23	-2.43	-3.62	-2.75	-4.58

NGL Fine-Chem Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-13 Mil.

NGL Fine-Chem (BOM:524774) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NGL Fine-Chem's Interest Expense for the three months ended in Mar. 2024 was ₹-5 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹126 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹7 Mil.

NGL Fine-Chem's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	125.632	/	-4.58
	=	27.43

The higher the ratio, the stronger the company's financial strength is.

NGL Fine-Chem (BOM:524774) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NGLFINE:India

Address

301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website

https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines